S.C.H.O.O.L.S empowers underserved populations to score A+ results
vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes[...]
Quarterly Report for Quarter Ending June 30, 2024 (Form 10-Q)
07/26/2024 | Press release | Distributed by Public on 07/26/2024 02:48
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact